In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis

European Journal of Pharmacology

Volumn 308, Issue 3, 1996, Pages 261-269

  Gainetdinov, Raul R ^a   Sotnikova, Tatyana D ^a   Grekhova, Tatyana V ^a   Rayevsky, Kirill S ^a  

^a INSTITUTE OF PHARMACOLOGY   (Russian Federation)

Author keywords

7 OH DPAT (7 hydroxy 2 (di n propylamino)tetralin); Dopamine D2 receptor; Dopamine D3 receptor; Dopamine release; Dopamine synthesis; Microdialysis

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3 HYDROXYBENZYLHYDRAZINE; 3,4 DIHYDROXYPHENYLACETIC ACID; 5 METHOXY 1 METHYL 2 PROPYLAMINOTETRALIN; DOPA; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT; DOPAMINE AUTORECEPTOR; HALOPERIDOL; PRESYNAPTIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINE RELEASE; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REGIONAL PERFUSION; REGULATORY MECHANISM;

EID: 0030601257     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00300-7     Document Type: Article

References (56)

1. 3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat, Eur. J. Pharmacol. 260, 177.
2. Arbila, S. and S.Z. Langer, 1981, Stereoselectivity of presynaptic autoreceptors modulating dopamine release, Eur. J. Pharmacol. 76, 345.
3. 3-preferring ligands act at synthesis modulating autoreceptors, J. Pharmacol. Exp. Ther. 274, 609.
4. 2, Neuropsychopharmacology 10, 237S.
5. Booth R.G., R.J. Baldessarini, E. Marsh and C.E. Owens, 1994, Actions of (±)-7-hydroxy-N,N-dipropylaminotetralin (7-OH-DPAT) on dopamine synthesis in limbic and extrapyramidal regions of rat brain, Brain Res. 662, 283.
6. 2 dopamine receptor antibodies using sequence-specific peptides, Mol. Pharmacol. 43, 666.
7. 3 dopamine receptors, Neuropsychopharmacology 12, 335.
8. Caine, S.B. and G.F. Koob, 1993, Modulation of cocaine self-administration in the rat through D-3 dopamine receptors, Science 260, 1814.
9. Carlsson, A., 1975, Receptor-mediated control of dopamine metabolism, in: Pre-and Postsynaptic Receptors, eds. E. Usdin and S. Snyder (Dekker, New York) p. 49.
10. 2 dopamine receptors, Mol. Pharmacol. 45, 51.
11. Daly, S.A. and J.L. Waddington, 1993, Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2-like" agonists, Neuropharmacology 32, 509.
12. 3 agonist, Soc. Neurosci. Abstr. 19, 77.
13. 3 receptor ligand, Eur. J. Pharmacol. 249, R9.
14. Devoto, P., M. Collu, A.L. Muntoni, M. Pistis, G. Serra, G.L. Gessa and M. Diana, 1995, Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system, Synapse 20, 153.
15. Di Chiara, G., M.L. Porceddu, W. Fratta and G.L. Gessa, 1977, Postsynaptic receptors are not essential for dopaminergic feedback regulation, Nature 267, 270.
16. El Mestikawy, S., J. Glowinski and M. Hamon, 1986, Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals, J. Neurochem. 46, 12.
17. Feenstra, M.G.P., C. Sumners, J.H. Goedemoed, J.B. De Vries, H. Rollema and A.S. Horn, 1983, A comparison of the potencies of various dopamine receptors agonists in models for pre-and postsynaptic receptor activity, Naunyn-Schmied. Arch Pharmacol. 324, 108.
18. 3 dopamine receptor, J. Pharmacol. Exp. Ther. 268, 417.
19. 3 receptor preferring antagonists differentially affect striatal dopamine release and metabolism in conscious rats, Eur. J. Pharmacol. 261, 327.
20. 3 receptor selective agonist 7-OH-DPAT in the dorsal striatum of freely moving rats, Neurosci. Lett. 193, 65.
21. 3 autoreceptor-mediated effects, Pharmacol. Biochem. Behav. 52, 275.
22. Gingrich, J.A. and M.G. Caron, 1993, Recent advances in the molecular biology of dopamine receptors, Ann. Rev. Neurosci. 16, 299.
23. 3 receptors are elevated in mesolimbic dopamine system of schizophrenics; receptor autoradiographic studies, Neuropsychopharmacology 10, 236S.
24. 3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin, Brain Res. 648, 222.
25. 2 receptors in basal ganglia and cortex of human brain, J. Pharmacol. Exp. Ther. 257, 1253.
26. Imperato, A., G. Tanda, R. Frau and G. Di Chiara, 1988, Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats, J. Pharmacol. Exp. Ther. 245, 257.
27. 4 dopamine receptors determined in transfected cell lines, Clin. Neuropharmacol. 18, Suppl. 1, S25.
28. 3 receptor: Chinese hamsters or Chinese Whispers, Trends Pharmacol. Sci, 15, 46.
29. 3 autoreceptors inhibits firing of ventral tegmental dopaminergic neurones in vivo, Eur. J. Pharmacol. 275, R7.
30. 3H]hydroxy-N,N-di-n-propyl-2 aminotctralin, Proc. Natl. Acad. Sci. USA 89, 8155.
31. 3 receptor agonist 7-OH-DPAT: lack of mesolimbic selectivity, Eur. J. Pharmacol. 264, 269.
32. 3 receptors, Eur. J. Pharmacol. 249, R5.
33. Mulder, T.B.A., J.B. De Vries, J.W. Wiechers, C.J. Grol and A.S. Horn, 1987, Further in vitro and in vivo studies with the putative presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin, Naunyn-Schmied. Arch. Pharmacol. 336, 494.
34. O'Hara, C.M., K.M. O'Malley and R.D. Todd, 1994, Autoreceptor regulation of dopamine synthesis in a mouse mesencephalic cell line, Soc. Neurosci. Abstr. 20, 644.
35. Paxinos, G. and C. Watson, 1982, The Rat Brain Stereotaxic Coordinates (Academic Press, Sydney).
36. Roth, R.H., 1983, Neuroleptics: functional neurochemistry, in: Neuroleptics: Neurochemical, Behavioural and Clinical Perspectives, eds. J.T. Coyle and S.J. Enna (Raven, New York) p, 119.
37. 3 receptor antagonist, (+)-S 14297, Eur. J. Pharmacol. 265, 175.
38. Santiago, M. and B.H.C. Westerink, 1990, Role of adenylate cyclase in the modulation of the release of dopamine: a microdialysis study in the striatum of the rat, J. Neurochem. 55, 169.
39. Santiago, M. and B.H.C. Westerink, 1991, The regulation of dopamine release from nigrostnatal neurons in conscious rats: the role of somatodendritic autoreceptors, Eur. J. Pharmacol. 204, 79.
40. 2 receptors, Neuroreport 6, 329.
41. Seeman, P. and H.H.M. Van Tol, 1994, Dopamine receptor pharmacology, Trends Pharmacol. Sci. 15, 264.
42. 3) as a target for neuroleptics, Nature 347, 146.
43. Stähle, L., 1992, Do autoreceptors mediate dopamine agonist-induced yawning and supression of exploration?, A critical review, Psychopharmacology 106, 1.
44. Stamford, J.A., Z.L. Kruk and J. Millar, 1991, Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data, Br. J. Pharmacol. 102, 45.
45. 3 receptors, Eur. J. Pharmacol. 263, 235.
46. 3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release, J. Neural Transm. 95, 71.
47. 4 dopamine receptors in fibroblast and dopaminergic cell lines, J. Pharmacol. Exp. Ther. 268, 495.
48. 3 receptors inhibit dopamine release, J. Pharmacol. Exp. Ther. 270, 475.
49. Timmerman, W., J.B. De Vries and B.H.C. Westerink, 1990, Effects of D-2 agonists on the release of dopamine: localization of the mechanism of action, Naunyn-Schmied. Arch. Pharmacol. 342, 650.
50. 3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study, Eur. J. Pharmacol. 242, 151.
51. 3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity, J. Neural. Transm. (Gen. Sect.) 94, 11.
52. Westerink, B.H.C. and J.B. De Vries, 1989, On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals, Neurosci. Lett. 99, 197.
53. Westerink, B.H.C., J.B. De Vries and R. Duran, 1990, Use of microdialysis for monitoring tyrosine hydroxylase activity in the brain of conscious rats, J. Neurochem. 54, 381.
54. Yamada, S., H. Yokoo and S. Nishi, 1994, Differential effects of dopamine agonists on evoked dopamine release from slices of striatum and nucleus accumbens in rats, Brain Res. 648, 176.
55. Zetterström, T. and U. Ungerstedt, 1984, Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain microdialysis, Eur. J. Pharmacol. 97, 29.
56. Zetterström, T., T. Sharp, A.K. Collin and U. Ungerstedt, 1988, In vivo measurement of extracellular dopamine and DOPAC in striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC, Eur. J. Pharmacol. 148, 327.